GlassScriptPhysician profile
Asma S Khan
NPI 1376663294
$16,762.76
in general payments reported to CMS, 2019-2025
52 companies · $2,424 in 2025
The $2,424 reported for 2025 was more than what 80% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,572 · 2020: $7,109 · 2021: $313 · 2022: $1,036 · 2023: $1,943 · 2024: $2,365 · 2025: $2,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,682 · Education: $50.20.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,681.97 |
| Education | $50.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $6,636.60 | 2019-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Novo Nordisk INC | $1,373.89 | 2019-2025 | Rybelsus, Ozempic |
| Lilly USA, LLC | $1,118.03 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Abbott Laboratories | $1,112.19 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $913.15 | 2019-2025 | Jardiance |
| Medtronic, INC. | $568.15 | 2023-2025 | Minimed 780g, Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Sanofi-Aventis U.S. LLC | $350.77 | 2019-2025 | |
| Cequr Corporation | $315.00 | 2023-2025 | Cequr Simplicity |
| Amgen INC. | $287.34 | 2019-2025 | Tepezza, Evenity, Prolia |
| Insulet Corporation | $285.83 | 2019-2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $281.38 | 2022-2025 | |
| Dexcom, INC. | $278.88 | 2022-2025 | Dexcom G6 Transmitter |
| Mannkind Corporation | $240.95 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $216.71 | 2019-2022 | |
| Ascendis Pharma Endocrinology INC | $214.15 | 2023-2025 | Yorvipath |
Show all 52 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $209.90 | 2019-2025 | |
| Xeris Pharmaceuticals, INC. | $206.09 | 2023-2025 | Gvoke Hypopen, Recorlev |
| Chiesi USA, INC. | $173.64 | 2022-2025 | Mycapssa, Myalept |
| Abbvie INC. | $165.89 | 2020-2025 | |
| Beta Bionics, INC. | $144.05 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Corcept Therapeutics | $137.06 | 2019-2025 | Korlym |
| Neurocrine Biosciences, INC. | $114.03 | 2024-2025 | |
| Horizon Therapeutics Plc | $112.32 | 2020-2023 | Tepezza |
| Madrigal Pharmaceuticals | $109.90 | 2024-2025 | Resmetirom, Rezdiffra |
| Kyowa Kirin, INC. | $105.72 | 2022-2023 | Crysvita |
| Sequel Med Tech, LLC | $100.34 | 2025 | Twiist |
| Amneal Pharmaceuticals LLC | $91.13 | 2023-2024 | Unithroid |
| Merck Sharp & Dohme LLC | $84.12 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $81.86 | 2023-2024 | |
| Radius Health, INC. | $68.88 | 2019-2025 | Tymlos |
| Medtronic Minimed, INC. | $59.08 | 2019-2020 | |
| Intuity Medical INC | $56.47 | 2022 | |
| Antares Pharma, INC. | $54.54 | 2022-2023 | Nocdurna, Tlando, Xyosted |
| Ibsa Pharma INC. | $49.54 | 2023-2024 | Licart, Tirosint, Tirosint |
| Amarin Pharma, INC. | $46.13 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $41.48 | 2019-2024 | Strensiq |
| Esperion Therapeutics, INC. | $39.35 | 2025 | Nexletol |
| Boston Scientific Corporation | $38.01 | 2022-2025 | General - Erectile Dysfunction |
| Amryt Pharma Holdings LTD | $26.90 | 2023 | Mycapssa |
| Nevro Corp. | $26.82 | 2023 | Senza |
| Shire North American Group INC | $26.40 | 2019 | |
| Baxter Healthcare | $25.89 | 2025 | Hillrom - Retinavue 700 Imager |
| Halozyme INC | $24.81 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $21.00 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $19.79 | 2024 | Imcivree |
| Janssen Pharmaceuticals, INC | $19.11 | 2019 | |
| Evoke Pharma, INC. | $17.91 | 2024 | |
| Recordati_rare_diseases_inc. | $16.69 | 2022 | |
| Intra-Sana Laboratories | $16.25 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Aegerion Pharmaceuticals, INC. | $13.78 | 2019 | |
| Currax Pharmaceuticals LLC | $13.54 | 2024 | Contrave |
| Glaxosmithkline, LLC. | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asma Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.